Evidence map›Paper›PMID 32968016›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Trajectory and uniqueness of mutational signatures in yeast mutators.

Sophie Loeillet, Mareike Herzog, Fabio Puddu, Patricia Legoix, Sylvain Baulande, Stephen P Jackson, Alain G Nicolas

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sophie LoeilletInstitut Curie, Paris Sciences et Lettres Research University, CNRS, UMR3244, 75248 Paris Cedex 05, France.ORCID 0000-0002-5613-3000
Mareike HerzogWellcome/Cancer Research UK Gurdon Institute and Department of Biochemistry, Cambridge CB2 1QN, United Kingdom.ORCID 0000-0001-9747-2327
Fabio PudduWellcome/Cancer Research UK Gurdon Institute and Department of Biochemistry, Cambridge CB2 1QN, United Kingdom.ORCID 0000-0002-2033-5209
Patricia LegoixICGex NGS Platform, Institut Curie, 75248 Paris Cedex 05, France.
Sylvain BaulandeICGex NGS Platform, Institut Curie, 75248 Paris Cedex 05, France.ORCID 0000-0003-3104-1684
Stephen P JacksonWellcome/Cancer Research UK Gurdon Institute and Department of Biochemistry, Cambridge CB2 1QN, United Kingdom.ORCID 0000-0001-9317-7937
Alain G NicolasInstitut Curie, Paris Sciences et Lettres Research University, CNRS, UMR3244, 75248 Paris Cedex 05, France; alain.nicolas@curie.fr.
The Gurdon Institute · GBCentre National de la Recherche Scientifique · FRInstitut Curie · FR

Funding

Cancer Research UK 18796Cancer Research UK C6946/A24843Cancer Research UK C6/A18796Wellcome TrustWellcome Trust 098051Wellcome Trust 101126/Z/13/ZWellcome Trust 206388/Z/17/ZWellcome Trust WT203144
6 · The paper itself

Abstract

The acquisition of mutations plays critical roles in adaptation, evolution, senescence, and tumorigenesis. Massive genome sequencing has allowed extraction of specific features of many mutational landscapes but it remains difficult to retrospectively determine the mechanistic origin(s), selective forces, and trajectories of transient or persistent mutations and genome rearrangements. Here, we conducted a prospective reciprocal approach to inactivate 13 single or multiple evolutionary conserved genes involved in distinct genome maintenance processes and characterize de novo mutations in 274 diploid

Indexed as

AcetyltransferasesBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCarcinogenesisDiploidyDNA DamageDNA-Directed DNA PolymeraseFemaleFlap EndonucleasesGenome, FungalHumansLoss of HeterozygosityMembrane ProteinsMutationPeroxiredoxinsAcetyltransferasesBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanDNA-Directed DNA PolymeraseDNA polymerase zetaELO2 protein, S cerevisiaeFlap EndonucleasesMembrane ProteinsPeroxiredoxinsPRDX1 protein, humanRAD27 protein, S cerevisiaeRad51 RecombinaseSaccharomyces cerevisiae Proteinsdynamics of mutation accumulationloss of heterozygositymutational profilesmutator genesPol zeta

Identifiers

PMID32968016
PMCPMC7547211
OpenAlexW3088048423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.